Olaine, 2016-02-15 07:41 CET (GLOBE NEWSWIRE) --
January 2016, consolidated sales | Sales, thsnd. EUR | Changes to January 2015 | Share in total sales |
Russia | 2 260 | -1% | 26% |
Latvia | 2 122 | 1% | 24% |
Belarus | 1 520 | 1001% | 17% |
UK | 866 | 3% | 10% |
Ukraine | 786 | -30% | 9% |
Poland | 230 | NA | 3% |
Kazakhstan | 207 | 286% | 2% |
Germany | 198 | NA | 2% |
Turkmenistan | 165 | 674% | 2% |
Italy | 117 | 257% | 1% |
Other | 368 | -68% | 4% |
Total | 8 840 | 14% | 100% |
Sales of pharmacy chain of SIA Latvijas aptieka during January 2016 were 1.66 million EUR, which represents an increase by 16% compared to the same period of 2015. 62 pharmacies were operating during January. Sales of SIA Silvanols during January 2016 were 0.32 million euros, which represents a reduction by 18% compared to January 2015. During January 2016 SIA Silvanols sold its products to six European countries, and with mediation of AS Olainfarm also to Kazakhstan and Belarus.
According to preliminary unconsolidated results, sales of AS Olainfarm in January 2016 were 7.76 million euros, which represents an increase by 19% compared to the same period one year ago. The biggest sales increase was achieved in Belarus, where sales gre by 1001%. Sales to Turkmenistan grew by 674%, sales to Kazakhstan grew by 286%, but sales to Italy grew by 257%. During January 2016, significant shipments were also made to Poland and Germany. The Major sales markets of AS Olainfarm during this period were Russia, Belarus, Latvia, UK and Ukraine. During January of 2016, products of AS Olainfarm were sold to 21 countries in Europe and Asia.
January 2016, unconsolidated sales | Sales, thsnd. EUR | Changes to January 2015 | Share in total sales |
Russia | 2 260 | -1% | 29% |
Belarus | 1 520 | 1001% | 20% |
Latvia | 1 192 | 1% | 15% |
UK | 866 | 3% | 11% |
Ukraine | 786 | -30% | 10% |
Kazakhstan | 207 | 286% | 3% |
Germany | 198 | NA | 3% |
Poland | 180 | NA | 2% |
Turkmenistan | 165 | 674% | 2% |
Italy | 117 | 257% | 2% |
Other | 265 | -69% | 3% |
Total | 7 758 | 19% | 100% |
According to preliminary estimates of AS Olainfarm, unconsolidated sales of the company in 2016 will reach 90 million euros, while consolidated sales will reach 103 million euros. According to these preliminary sales figures, during January 2016 the company has attained 9% of its annual target for unconsolidated sales and 9% of its annual target for consolidated sales.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv